Esperanza Merino to Prognosis
This is a "connection" page, showing publications Esperanza Merino has written about Prognosis.
Connection Strength
0.050
-
Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study. J Autoimmun. 2020 11; 114:102523.
Score: 0.040
-
Fatality and risk features for prognosis in COVID-19 according to the care approach - a retrospective cohort study. PLoS One. 2021; 16(3):e0248869.
Score: 0.010